Introduction to prostate cancer

Imaging in Clinical Oncology

Volumn , Issue , 2014, Pages 553-557

  Alivizatos, Gerasimos J ^a  

^a NONE   (Greece)

Author keywords

Computerized tomography (CT); Imaging modalities; Magnetic resonance imaging (MRI); Positron emission tomography (PET); Prostate cancer; Transrectal ultrasonography

Indexed keywords

DIAGNOSIS; DISEASES; MAGNETIC RESONANCE IMAGING; PATIENT TREATMENT; POSITRON EMISSION TOMOGRAPHY; UROLOGY;

IMAGING MODALITY; MAGNETIC RESONANCE IMAGING (MRI); POSITRON EMISSION TOMOGRAPHY (PET); PROSTATE CANCERS; TRANSRECTAL ULTRASONOGRAPHY;

COMPUTERIZED TOMOGRAPHY;

EID: 84941356658     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-88-470-5385-4_89     Document Type: Chapter

References (16)

1. Center MM, Jemal A, Lortet-Tieulent J et al (2012) International variation in prostate cancer incidence and mortality rates. Eur Urol 61(6):1079-1092
2. Jemal A, Bray F, Center MM et al (2011) Global cancer statistics, 2008. CA Cancer J Clin 61:69-90
3. Centers of Medicare and Medicaid Services (2009) National health expenditure fact sheet. US Department of Health and Human Services, Baltimore
4. Epstein JI, Allsbrook WC Jr, Amin MB et al (2005) ISUP grading committee. The 2005 international society of urologic pathology (ISUP) consensus conference on gleason grading of prostatic Carcinoma. Am J Surg Pathol 29(9):1228-1242
5. Sobin LH, Gospodariwicz M, Wittekind C (eds) (2009) TNM classification of malignant tumours.
6. UICC international union against cancer, 7th edn. Wiley, New York, pp 243-248
7. Heidenreich A, Bellmunt J, Bolla M et al (2011) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59(1):61-71
8. Schroder FH, Hugosson J, Roobol MJ et al (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360(13):1320-1328
9. Andriole GL, Crawford ED, Grubb RL 3rd et al (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360(13):1310-1319
10. Xiaoye Z, Albertsen P, Andriole G et al (2012) Risk based prostate cancer screening. Eur Urol 61(4):652-661
11. Gravas S, Mamoulakis Ch, Rioja J et al (2009) Advances in ultrasound technology in oncologic urology. Urol Clin N Am 36(2):133-145
12. Partin AW, Mangold LA, Lamm DM et al (2001) Contemporary update of the prostate cancer staging nomograms (Partin tables) for the new millennium. Urology 58(6):843-848
13. Pinto F, Totaro A, Palermo G et al (2012) Imaging in prostate cancer staging: present role and future perspectives. Urol Int 88(2):125-136
14. Cagiannos I, Karakiewicz P, Eastham JA et al (2003) A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 170(5):1798-1803
15. Haese A, Epstein JI, Huland H et al (2002) Validation of a biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinoma. Cancer 95(5):1016-1021
16. Castellucci P, Fuccio C, Rubello D et al (2011) Is there a role for C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml? Eur J Nucl Med Mol Imaging 38(1):55-63